Difference between revisions of "Mendel Biotechnology"

From Powerbase
Jump to: navigation, search
(Collaborators: Monsanto, Bayer, BP)
Line 14: Line 14:
  
 
Mendel's deal with Bayer involved "developing chemical products which make crops more resistant to biotic and abiotic stress factors, which in turn will stabilize yields and improve crop productivity".<ref>[http://www.mendelbio.com/newsevents/annual_report_2009.pdf Dear Shareholder], Mendel Biotechnology Annual Report 2009, p. 4, acc 8 Jul 2010</ref>
 
Mendel's deal with Bayer involved "developing chemical products which make crops more resistant to biotic and abiotic stress factors, which in turn will stabilize yields and improve crop productivity".<ref>[http://www.mendelbio.com/newsevents/annual_report_2009.pdf Dear Shareholder], Mendel Biotechnology Annual Report 2009, p. 4, acc 8 Jul 2010</ref>
 +
 +
Mendel says its program with Bayer "is a continuation of previous joint activities which focused on the elucidation of stress response mode of actions of Bayer agrochemicals like Imidacloprid and Trifloxystrobin".<ref>[http://www.mendelbio.com/strategicpartners/index.php Strategic partners], Mendel Biotechnology website, acc 8 Jul 2010</ref>
  
 
==Patents owned==
 
==Patents owned==

Revision as of 11:21, 8 July 2010

Mendel Biotechnology, Inc. says it aims "to produce plants enhanced for food, feed, fiber, energy and aesthetic benefit without large increases in production acreage" and says it is

dedicated to being a premier biotechnology company serving large agricultural companies with new genetic and chemical solutions and to becoming the leading seed company serving the bioenergy industry.[1]

Collaborators: Monsanto, Bayer, BP

On its website, the company names Monsanto as "Mendel's most important customer and collaborator for our technology business".[2]

In its 2008 Annual Report it lists two lines of business that were central to its growth in that year:

  • a collaborative project with Monsanto on soybean yield, "the basis of which is a Mendel technology"[3]
  • the establishment of "the first-ever field trials of genetically diverse Miscanthus varieties for biomass production in the United States"[4]

Mendel's 2009 Annual Report names 2009 as a "watershed year", demonstrated by two collaborative partnerships: one with Monsanto and the other with Bayer CropScience.[5]

Mendel's deal with Monsanto involved Monsanto's "initial deployment of our [Mendel's] platforms" for its "improved yield soybean".[6]

Mendel's deal with Bayer involved "developing chemical products which make crops more resistant to biotic and abiotic stress factors, which in turn will stabilize yields and improve crop productivity".[7]

Mendel says its program with Bayer "is a continuation of previous joint activities which focused on the elucidation of stress response mode of actions of Bayer agrochemicals like Imidacloprid and Trifloxystrobin".[8]

Patents owned

As at July 2010, Mendel had been granted over 20 biotechnology and GM patents, as listed on its website.[9] Its interests include developing "energy grasses" for biomass and biofuels.[10]

Affiliations

As at June 2010, Mendel's "strategic partners" are:[11]

  • Monsanto. Mendel calls Monsanto its "most important customer and collaborator for our technology business".[12]
  • BP
  • Bayer CropScience
  • Selecta Klemm: a joint venture formed in 2006 — Ornamental Biosciences, Inc. — for the commercialization of ornamental crop varieties differentiated in the marketplace for improved growth and survival under a range of stresses.
  • SweTree Technologies: a collaboration for the development of improved varieties of plantation forest tree species.
  • ArborGen: a collaboration to improve stress tolerance in selected tree species.

People

Scientific advisory board

As of June 2010:[13]

Funding

Contact

As at July 2010:[14]

Address: Mendel Biotechnology, 3935 Point Eden Way, Hayward, CA 94545
Phone 510-264-0280
Fax 510-264-0254
http://www.Mendelbio.com

Resources

Notes

  1. Our mission, Mendel Biotechnology website, acc 9 Jun 2010
  2. Strategic partners, Mendel Biotechnology website, acc 8 Jul 2010
  3. Mendel Biotechnology Annual Report 2008, p 4, acc 8 Jul 2010
  4. Mendel Biotechnology Annual Report 2008, p 4, acc 8 Jul 2010
  5. Dear Shareholder, Mendel Biotechnology Annual Report 2009, p. 4, acc 8 Jul 2010
  6. Dear Shareholder, Mendel Biotechnology Annual Report 2009, p. 4, acc 8 Jul 2010
  7. Dear Shareholder, Mendel Biotechnology Annual Report 2009, p. 4, acc 8 Jul 2010
  8. Strategic partners, Mendel Biotechnology website, acc 8 Jul 2010
  9. Issued patents, Mendel Biotechnology website, acc 8 July 2010
  10. Mendel Biotechnology Annual Report 2008, p 4, acc 8 Jul 2010
  11. Strategic Partners, Mendel Biotechnology website, acc 9 Jun 2010
  12. Strategic Partners, Mendel Biotechnology website, acc 9 Jun 2010
  13. Scientific Advisory Board, Mendel Biotechnology website, acc 9 Jun 2010
  14. Mendel Biotechnology Annual Report 2009, acc 8 Jul 2010